{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:19:25Z","timestamp":1789039165629,"version":"build-2803163510"},"reference-count":163,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.coviro.2023.101301","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T06:27:20Z","timestamp":1676615240000},"page":"101301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["HIV persistence: silence or resistance?"],"prefix":"10.1016","volume":"59","author":[{"given":"Alexander O","family":"Pasternak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Berkhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2023.101301_bib1","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2023.101301_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2023.101301_bib3","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/infdis\/jiv218","article-title":"Precise quantitation of the latent HIV-1 reservoir: implications for eradication strategies","volume":"212","author":"Crooks","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2023.101301_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","author":"Chomont","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2023.101301_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.1254194","article-title":"HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells","volume":"345","author":"Maldarelli","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.coviro.2023.101301_bib6","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.1256304","article-title":"HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection","volume":"345","author":"Wagner","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.coviro.2023.101301_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature16933","article-title":"Persistent HIV-1 replication maintains the tissue reservoir during therapy","volume":"530","author":"Lorenzo-Redondo","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nature10347","article-title":"Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy","volume":"477","author":"Sigal","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_bib9","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.1318249111","article-title":"Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues","volume":"111","author":"Fletcher","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2023.101301_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02251","article-title":"The quest for cellular markers of HIV reservoirs: any color you like","volume":"10","author":"Darcis","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2023.101301_bib11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41564-018-0335-z","article-title":"HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy","volume":"4","author":"Ganor","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coviro.2023.101301_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.chom.2020.03.014","article-title":"The biology of the HIV-1 latent reservoir and implications for cure strategies","volume":"27","author":"Cohn","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2023.101301_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-pathol-050520-112001","article-title":"In vivo dynamics of the latent reservoir for HIV-1: new insights and implications for cure","volume":"17","author":"Siliciano","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.coviro.2023.101301_bib14","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1172\/JCI136227","article-title":"The multifaceted nature of HIV latency","volume":"130","author":"Dufour","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coviro.2023.101301_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cell.2020.03.005","article-title":"Curing HIV: seeking to target and clear persistent infection","volume":"181","author":"Margolis","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2023.101301_bib16","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.coviro.2023.101301_bib17","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/QAD.0000000000000822","article-title":"Quantification of naive and memory T-cell turnover during HIV-1 infection","volume":"29","author":"Vrisekoop","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2023.101301_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/imr.12693","article-title":"Current best estimates for the average lifespans of mouse and human leukocytes: reviewing two decades of deuterium-labeling experiments","volume":"285","author":"Borghans","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coviro.2023.101301_bib19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.celrep.2017.09.081","article-title":"Identification of genetically intact HIV-1 proviruses in specific CD4(+) T cells from effectively treated participants","volume":"21","author":"Hiener","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2023.101301_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009214","article-title":"Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART","volume":"17","author":"Bacchus-Souffan","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2023.101301_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02447-21","article-title":"HIV-1 genomes are enriched in memory CD4+ T-cells with short half-lives","volume":"12","author":"Morcilla","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2023.101301_bib22","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1128\/JVI.00492-07","article-title":"Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4\/CD8 double-negative T lymphocytes","volume":"81","author":"Kaiser","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101301_bib23","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1172\/JCI26197","article-title":"HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir","volume":"115","author":"Chun","year":"2005","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coviro.2023.101301_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/QAD.0000000000002465","article-title":"High levels of genetically intact HIV in HLA-DR+ memory T cells indicates their value for reservoir studies","volume":"34","author":"Horsburgh","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2023.101301_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02214","article-title":"Memory CD4+ T-cells expressing HLA-DR contribute to HIV persistence during prolonged antiretroviral therapy","volume":"10","author":"Lee","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2023.101301_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06843-5","article-title":"A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation","volume":"9","author":"Reeves","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2023.101301_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/v13102078","article-title":"Clonal expansion of infected CD4+ T cells in people living with HIV","volume":"13","author":"Coffin","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2023.101301_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/v13122512","article-title":"Why the HIV reservoir never runs dry: clonal expansion and the characteristics of HIV-infected cells challenge strategies to cure and control HIV infection","volume":"13","author":"Lau","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2023.101301_sbref29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009141","article-title":"Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy","volume":"17","author":"Coffin","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2023.101301_bib30","first-page":"E2575","article-title":"Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane","volume":"115","author":"Wang","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2023.101301_bib31","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200051","article-title":"Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir","volume":"217","author":"Mendoza","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2023.101301_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145254","article-title":"Antigen-driven clonal selection shapes the persistence of HIV-1-infected CD4+ T cells in vivo","volume":"131","author":"Simonetti","year":"2021","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coviro.2023.101301_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature13594","article-title":"Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys","volume":"512","author":"Whitney","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002417","article-title":"HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: an observational study","volume":"14","author":"Henrich","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.coviro.2023.101301_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw5589","article-title":"The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation","volume":"11","author":"Abrahams","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2023.101301_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18889","article-title":"Establishment and stability of the latent HIV-1 DNA reservoir","volume":"5","author":"Brodin","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.coviro.2023.101301_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008286","article-title":"Dynamics of HIV DNA reservoir seeding in a cohort of superinfected Kenyan women","volume":"16","author":"Pankau","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2023.101301_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-2-52","article-title":"Retroviral superinfection resistance","volume":"2","author":"Nethe","year":"2005","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2023.101301_bib39","series-title":"Introduction to Modern Virology","author":"Dimmock","year":"2007"},{"key":"10.1016\/j.coviro.2023.101301_bib40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.virol.2010.12.041","article-title":"HIV reservoirs and latency models","volume":"411","author":"Pace","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2023.101301_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9927","article-title":"HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing","volume":"10","author":"Yukl","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2023.101301_bib42","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/infdis\/jis502","article-title":"Modest nonadherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma","volume":"206","author":"Pasternak","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2023.101301_bib43","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/infdis\/jit308","article-title":"The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence","volume":"208","author":"Yukl","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2023.101301_sbref44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68174","article-title":"Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels as compared with therapy based on protease inhibitors","volume":"10","author":"Pasternak","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.coviro.2023.101301_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134196","article-title":"Cell-associated HIV-1 RNA predicts viral rebound and disease progression after discontinuation of temporary early ART","volume":"5","author":"Pasternak","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.coviro.2023.101301_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103241","article-title":"Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency","volume":"65","author":"Zerbato","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coviro.2023.101301_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037792","article-title":"Immune and viral correlates of \"secondary viral control\" after treatment interruption in chronically HIV-1 infected patients","volume":"7","author":"Van Gulck","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2023.101301_bib48","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1128\/JVI.78.17.9105-9114.2004","article-title":"Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo","volume":"78","author":"Lassen","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101301_bib49","doi-asserted-by":"crossref","first-page":"E3659","DOI":"10.1073\/pnas.1617961114","article-title":"Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART","volume":"114","author":"Wiegand","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2023.101301_sbref50","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cell.2021.12.011","article-title":"Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses","volume":"185","author":"Einkauf","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2023.101301_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/v13091751","article-title":"The splice of life: does RNA processing have a role in HIV-1 persistence?","volume":"13","author":"Pasternak","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2023.101301_bib52","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-018-0397-2","article-title":"What do we measure when we measure cell-associated HIV RNA","volume":"15","author":"Pasternak","year":"2018","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2023.101301_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-10-41","article-title":"Cell-associated HIV RNA: a dynamic biomarker of viral persistence","volume":"10","author":"Pasternak","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2023.101301_sbref54","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1172\/JCI138099","article-title":"HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus","volume":"130","author":"Halvas","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coviro.2023.101301_bib55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.immuni.2012.08.010","article-title":"Redefining the viral reservoirs that prevent HIV-1 eradication","volume":"37","author":"Eisele","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2023.101301_bib56","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.4156","article-title":"Defective proviruses rapidly accumulate during acute HIV-1 infection","volume":"22","author":"Bruner","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2023.101301_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08431-7","article-title":"Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion","volume":"10","author":"Pinzone","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2023.101301_bib58","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2023.101301_bib59","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1172\/JCI93289","article-title":"Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells","volume":"127","author":"Lee","year":"2017","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coviro.2023.101301_bib60","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1084\/jem.20190896","article-title":"Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir","volume":"216","author":"Gaebler","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2023.101301_bib61","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","article-title":"A quantitative approach for measuring the reservoir of latent HIV-1 proviruses","volume":"566","author":"Bruner","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_bib62","article-title":"A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir","volume":"2","author":"Levy","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.coviro.2023.101301_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103615","article-title":"HIV reservoir quantification using cross-subtype multiplex ddPCR","volume":"25","author":"Cassidy","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.coviro.2023.101301_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01986-20","article-title":"Sequence evaluation and comparative analysis of novel assays for intact proviral HIV-1 DNA","volume":"95","author":"Gaebler","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101301_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010845","article-title":"Measuring the latent reservoir for HIV-1: quantification bias in near full-length genome sequencing methods","volume":"18","author":"White","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2023.101301_bib66","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41586-020-2651-8","article-title":"Distinct viral reservoirs in individuals with spontaneous control of HIV-1","volume":"585","author":"Jiang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_bib67","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI124291","article-title":"Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy","volume":"129","author":"Einkauf","year":"2019","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coviro.2023.101301_bib68","doi-asserted-by":"crossref","first-page":"7801","DOI":"10.1093\/nar\/gkaa536","article-title":"The chromatin landscape at the HIV-1 provirus integration site determines viral expression","volume":"48","author":"Vansant","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.coviro.2023.101301_sbref69","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00007-22","article-title":"Single-cell imaging shows that the transcriptional state of the HIV-1 provirus and its reactivation potential depend on the integration site","volume":"13","author":"Janssens","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2023.101301_bib70","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/COH.0000000000000230","article-title":"Residual inflammation and viral reservoirs: alliance against an HIV cure","volume":"11","author":"Massanella","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.coviro.2023.101301_bib71","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/imr.12065","article-title":"Immune activation and HIV persistence: implications for curative approaches to HIV infection","volume":"254","author":"Klatt","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coviro.2023.101301_sbref72","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00099-21","article-title":"Cell-associated HIV-1 unspliced-to-multiply-spliced RNA ratio at 12 weeks of ART predicts immune reconstitution on therapy","volume":"12","author":"Scherpenisse","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2023.101301_bib73","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01920-18","article-title":"Characterization of intact proviruses in blood and lymph node from HIV-infected individuals undergoing analytical treatment interruption","volume":"93","author":"Vibholm","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101301_bib74","doi-asserted-by":"crossref","first-page":"E11341","DOI":"10.1073\/pnas.1813512115","article-title":"Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption","volume":"115","author":"Lu","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2023.101301_bib75","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1084\/jem.20180936","article-title":"Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117","volume":"215","author":"Cohen","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2023.101301_bib76","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.chom.2019.08.003","article-title":"HIV rebound is predominantly fueled by genetically identical viral expansions from diverse reservoirs","volume":"26","author":"De Scheerder","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2023.101301_sbref77","doi-asserted-by":"crossref","first-page":"32066","DOI":"10.1073\/pnas.2020617117","article-title":"Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1","volume":"117","author":"Bertagnolli","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2023.101301_sbref78","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd8179","article-title":"Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption","volume":"13","author":"Gondim","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2023.101301_bib79","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.it.2022.06.002","article-title":"An ordeal that does not heal: understanding barriers to a cure for HIV-1 infection","volume":"43","author":"Lichterfeld","year":"2022","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coviro.2023.101301_bib80","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cell.2021.12.038","article-title":"The loud minority: transcriptionally active HIV-1-infected cells survive, proliferate, and persist","volume":"185","author":"Collora","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2023.101301_bib81","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cell.2013.09.039","article-title":"Stochastic fate selection in HIV-infected patients","volume":"155","author":"Weinberger","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2023.101301_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02204","article-title":"HIV infected T cells can proliferate in vivo without inducing expression of the integrated provirus","volume":"10","author":"Musick","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2023.101301_sbref83","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109643","article-title":"Combined single-cell transcriptional, translational, and genomic profiling reveals HIV-1 reservoir diversity","volume":"36","author":"Sannier","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2023.101301_bib84","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.cell.2015.02.009","article-title":"A hardwired HIV latency program","volume":"160","author":"Razooky","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2023.101301_bib85","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2005.06.006","article-title":"Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity","volume":"122","author":"Weinberger","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2023.101301_bib86","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.chom.2019.10.006","article-title":"Principles governing establishment versus collapse of HIV-1 cellular spread","volume":"26","author":"Hataye","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2023.101301_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007357","article-title":"Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency","volume":"14","author":"Telwatte","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2023.101301_bib88","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.tig.2019.05.005","article-title":"Transcriptional control by premature termination: a forgotten mechanism","volume":"35","author":"Kamieniarz-Gdula","year":"2019","journal-title":"Trends Genet"},{"key":"10.1016\/j.coviro.2023.101301_bib89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-020-00308-8","article-title":"Causes and consequences of RNA polymerase II stalling during transcript elongation","volume":"22","author":"Noe Gonzalez","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.coviro.2023.101301_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.559998","article-title":"Gene size matters: an analysis of gene length in the human genome","volume":"12","author":"Lopes","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.coviro.2023.101301_bib91","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature14053","article-title":"Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations","volume":"517","author":"Deng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_bib92","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1172\/JCI135953","article-title":"Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy","volume":"130","author":"Antar","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coviro.2023.101301_bib93","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1172\/JCI97555","article-title":"Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells","volume":"128","author":"Huang","year":"2018","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coviro.2023.101301_bib94","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.immuni.2018.04.004","article-title":"Anti-apoptotic protein BIRC5 maintains survival of HIV-1-infected CD4","volume":"48","author":"Kuo","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2023.101301_bib95","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1172\/JCI132374","article-title":"BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo","volume":"130","author":"Ren","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coviro.2023.101301_bib96","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature21710","article-title":"CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses","volume":"543","author":"Descours","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_bib97","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.celrep.2020.01.071","article-title":"CD32+CD4+ T cells are highly enriched for HIV DNA and can support transcriptional latency","volume":"30","author":"Darcis","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2023.101301_sbref98","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78294","article-title":"Identification of HIV-reservoir cells with reduced susceptibility to antibody-dependent immune response","volume":"11","author":"Astorga-Gamaza","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.coviro.2023.101301_sbref99","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.immuni.2022.03.004","article-title":"Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones","volume":"55","author":"Collora","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2023.101301_bib100","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150794","article-title":"Naive infection predicts reservoir diversity and is a formidable hurdle to HIV eradication","volume":"6","author":"Pinzone","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.coviro.2023.101301_bib101","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133157","article-title":"Persistence of an intact HIV reservoir in phenotypically naive T cells","volume":"5","author":"Venanzi Rullo","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.coviro.2023.101301_bib102","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/cid\/ciz108","article-title":"Cells harbor a large inducible reservoir of latent, replication-competent human immunodeficiency virus type 1","volume":"69","author":"Zerbato","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2023.101301_sbref103","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154422","article-title":"The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells","volume":"132","author":"Duette","year":"2022","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coviro.2023.101301_bib104","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/COH.0000000000000287","article-title":"Persistent HIV-1 replication during antiretroviral therapy","volume":"11","author":"Martinez-Picado","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.coviro.2023.101301_bib105","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.4411","article-title":"Defining total-body AIDS-virus burden with implications for curative strategies","volume":"23","author":"Estes","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2023.101301_bib106","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1073\/pnas.0804192105","article-title":"HIV rebounds from latently infected cells, rather than from continuing low-level replication","volume":"105","author":"Joos","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2023.101301_bib107","doi-asserted-by":"crossref","first-page":"E4987","DOI":"10.1073\/pnas.1308313110","article-title":"The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time","volume":"110","author":"Josefsson","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2023.101301_bib108","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav2045","article-title":"No evidence of ongoing HIV replication or compartmentalization in tissues during combination antiretroviral therapy: implications for HIV eradication","volume":"5","author":"Bozzi","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.coviro.2023.101301_bib109","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1172\/JCI94582","article-title":"No evidence of HIV replication in children on antiretroviral therapy","volume":"127","author":"Van Zyl","year":"2017","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coviro.2023.101301_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004010","article-title":"Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy","volume":"10","author":"Kearney","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2023.101301_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004677","article-title":"Residual Viremia in treated HIV+ individuals","volume":"12","author":"Conway","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.coviro.2023.101301_bib112","doi-asserted-by":"crossref","DOI":"10.3390\/v12050489","article-title":"Differences in HIV markers between infected individuals treated with different ART regimens: implications for the persistence of viral reservoirs","volume":"12","author":"Darcis","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2023.101301_bib113","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/QAD.0000000000002603","article-title":"First-line HIV treatment outcomes following the introduction of integrase inhibitors in UK guidelines","volume":"34","author":"El Bouzidi","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2023.101301_bib114","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/infdis\/jit453","article-title":"Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial","volume":"208","author":"Hatano","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2023.101301_bib115","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/infdis\/jiq138","article-title":"A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response","volume":"203","author":"Hatano","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2023.101301_bib116","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nm.2111","article-title":"HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects","volume":"16","author":"Buzon","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2023.101301_bib117","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2023.101301_bib118","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_bib119","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7326\/L21-0297","article-title":"A possible sterilizing cure of HIV-1 infection without stem cell transplantation","volume":"175","author":"Turk","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.coviro.2023.101301_bib120","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s41591-021-01590-5","article-title":"Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021","volume":"27","author":"Deeks","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2023.101301_bib121","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41586-019-1841-8","article-title":"Why and where an HIV cure is needed and how it might be achieved","volume":"576","author":"Ndung'u","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_sbref122","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103985","article-title":"Novel role of UHRF1 in the epigenetic repression of the latent HIV-1","volume":"79","author":"Verdikt","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coviro.2023.101301_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004473","article-title":"Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy","volume":"10","author":"Elliott","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2023.101301_bib124","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1016\/S2352-3018(16)30055-8","article-title":"Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B\/2A trial","volume":"3","author":"Leth","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.coviro.2023.101301_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005142","article-title":"The depsipeptide romidepsin reverses HIV-1 latency in vivo","volume":"11","author":"S\u00f8gaard","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2023.101301_bib126","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2352-3018(14)70014-1","article-title":"Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1\/2, single group, clinical trial","volume":"1","author":"Rasmussen","year":"2014","journal-title":"Lancet HIV"},{"key":"10.1016\/j.coviro.2023.101301_bib127","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-020-1951-3","article-title":"Systemic HIV and SIV latency reversal via non-canonical NF-\u03baB signalling in vivo","volume":"578","author":"Nixon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_bib128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-020-1946-0","article-title":"Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells","volume":"578","author":"McBrien","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_sbref129","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157281","article-title":"Combined noncanonical NF-\u03baB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo","volume":"132","author":"Falcinelli","year":"2022","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coviro.2023.101301_bib130","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2012.01.014","article-title":"Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation","volume":"36","author":"Shan","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2023.101301_bib131","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/S2666-5247(21)00239-1","article-title":"Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial","volume":"3","author":"Gruell","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.coviro.2023.101301_bib132","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0140-6736(19)32990-3","article-title":"Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial","volume":"395","author":"Fidler","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2023.101301_bib133","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax6795","article-title":"Different human resting memory CD4+ T cell subsets show similar low inducibility of latent HIV-1 proviruses","volume":"12","author":"Kwon","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2023.101301_bib134","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/infdis\/jiaa736","article-title":"Similar frequency and inducibility of intact HIV-1 proviruses in blood and lymph nodes","volume":"224","author":"Martin","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2023.101301_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/v12010084","article-title":"Block-and-lock strategies to cure HIV infection","volume":"12","author":"Vansant","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2023.101301_bib136","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41591-019-0412-8","article-title":"Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic","volume":"25","author":"Caskey","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2023.101301_bib137","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/QCO.0000000000000803","article-title":"Immunotherapeutic approaches to HIV cure and remission","volume":"35","author":"Lee","year":"2022","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.coviro.2023.101301_bib138","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-018-0531-2","article-title":"Combination therapy with anti-HIV-1 antibodies maintains viral suppression","volume":"561","author":"Mendoza","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_sbref139","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41586-022-04597-1","article-title":"Prolonged viral suppression with anti-HIV-1 antibody therapy","volume":"606","author":"Gaebler","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_sbref140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41586-022-04797-9","article-title":"Combination anti-HIV antibodies provide sustained virological suppression","volume":"606","author":"Sneller","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_sbref141","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41591-019-0747-1","article-title":"Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity","volume":"26","author":"Niessl","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2023.101301_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.855092","article-title":"HibeRNAtion: HIV-1 RNA metabolism and viral latency","volume":"12","author":"Crespo","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.coviro.2023.101301_bib143","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07753-2","article-title":"Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines","volume":"9","author":"McCauley","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2023.101301_bib144","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05899-7","article-title":"HIV-1 intron-containing RNA expression induces innate immune activation and T cell dysfunction","volume":"9","author":"Akiyama","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2023.101301_bib145","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/S0140-6736(20)32666-0","article-title":"Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study","volume":"396","author":"Overton","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2023.101301_bib146","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41586-018-0600-6","article-title":"Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys","volume":"563","author":"Borducchi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_sbref147","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201214","article-title":"Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia","volume":"218","author":"Nishimura","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2023.101301_bib148","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature21435","article-title":"Early antibody therapy can induce long-lasting immunity to SHIV","volume":"543","author":"Nishimura","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101301_bib149","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/COH.0000000000000749","article-title":"Towards a molecular profile of antiretroviral therapy-free HIV remission","volume":"17","author":"Adams","year":"2022","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.coviro.2023.101301_bib150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003211","article-title":"Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study","volume":"9","author":"S\u00e1ez-Ciri\u00f3n","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2023.101301_bib151","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.chom.2017.03.008","article-title":"Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes, which shape the proviral landscape","volume":"21","author":"Pollack","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2023.101301_bib152","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1073\/pnas.1917876117","article-title":"Defective HIV-1 proviruses produce viral proteins","volume":"117","author":"Imamichi","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2023.101301_bib153","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1073\/pnas.1609057113","article-title":"Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy","volume":"113","author":"Imamichi","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2023.101301_bib154","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-022-00601-8","article-title":"Defective HIV-1 genomes and their potential impact on HIV pathogenesis","volume":"19","author":"Kuniholm","year":"2022","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2023.101301_sbref155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142640","article-title":"HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy","volume":"6","author":"Stevenson","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.coviro.2023.101301_bib156","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132997","article-title":"Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy","volume":"5","author":"Peluso","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.coviro.2023.101301_bib157","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/infdis\/jiaa532","article-title":"Selective decay of intact HIV-1 proviral DNA on antiretroviral therapy","volume":"223","author":"Gandhi","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2023.101301_bib158","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2117630119","article-title":"Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing","volume":"119","author":"Cho","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2023.101301_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.862270","article-title":"Insights into persistent HIV-1 infection and functional cure: novel capabilities and strategies","volume":"13","author":"Ta","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2023.101301_bib160","doi-asserted-by":"crossref","DOI":"10.3390\/v14091980","article-title":"Forging a functional cure for HIV: transcription regulators and inhibitors","volume":"14","author":"Mediouni","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2023.101301_bib161","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211427","article-title":"Integration features of intact latent HIV-1 in CD4+ T cell clones contribute to viral persistence","volume":"218","author":"Huang","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2023.101301_bib162","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.it.2022.06.001","article-title":"Potential multi-modal effects of provirus integration on HIV-1 persistence: lessons from other viruses","volume":"43","author":"Linden","year":"2022","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coviro.2023.101301_bib163","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/COH.0000000000000687","article-title":"Assessing proviral competence: current approaches to evaluate HIV-1 persistence","volume":"16","author":"Cicilionyt\u0117","year":"2021","journal-title":"Curr Opin HIV AIDS"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625723000019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625723000019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:07:11Z","timestamp":1761818831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625723000019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":163,"alternative-id":["S1879625723000019"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2023.101301","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV persistence: silence or resistance?","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2023.101301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101301"}}